• English
• Español
• Français
• Deutsch
• 中文
• Português

• Store Login
• Cart
• Support

• About USP
  • Our impact
  • Where we're going
  • ISO certified
  • Governance
    • Convention Members
    • Board of Trustees
    • Council of Experts
    • Articles of Incorporation
    • Constitution & Bylaws
    • Policies and Rules
    • 2005 Convention
  • Executive team
  • History
  • International Locations
  • What's new
  • Newsletters
  • Press Room
  • Council of Experts Report
  • Public access to USP resources
  • Careers
  • Contact us
  • Directions to USP
• USP–NF
• Food Chemicals Codex
• Pending & Non-U.S. Standards
• Reference Standards
• USP Verified
• Pharmacopeial Education
• Healthcare Quality and Information (HQI)
• USP in Developing Countries
• Meetings
• Products

Constitution and Bylaws

Bylaws

Chapter III—The Executive Vice President and Chief Executive Officer (CEO)

Section 1

The Executive Vice President shall serve as the chief executive officer (CEO) of the Convention. The Executive Vice President-CEO shall be an ex officio, non-voting member of the Board of Trustees. The Executive Vice President-CEO shall function within the framework of the policies and programs as determined by the Executive Vice President-CEO after consultation with the Board of Trustees.

Section 2

The Executive Vice President-CEO shall be a member, ex officio, and Chairperson of the Council of Experts and of the Executive Committee of the Council of Experts.

Section 3

The Executive Vice President-CEO shall organize the Council of Experts in accordance with Chapter VII of these Bylaws. The Executive Vice President-CEO shall appoint any ad hoc advisory bodies required for the work of the Council.

Section 4

The Executive Vice President-CEO shall have charge of the work and shall cause to be prepared the final text of the United States Pharmacopeia, the National Formulary, and other authorized publications, and any supplements thereto.

Section 5

The Executive Vice President-CEO shall consult with the Executive Committee of the Council of Experts, and the Division Executive Committees (if appointed) on matters of general policy concerning the planning and executing of the United States Pharmacopeia, the National Formulary, other authorized publications, and of supplements thereto.

Section 6

The Executive Vice President-CEO shall annually or more frequently, upon request of the Board of Trustees, certify in writing to the Board of Trustees that a new United States Pharmacopeia and new National Formulary, or a new Supplement or any change thereto, has been prepared in accordance with the rules and procedures of the Council of Experts. The Executive Vice President-CEO shall also certify in writing to the Board of Trustees that an authorized publication or its supplement has been completed in accordance with existing rules and procedures.

Section 7

The Executive Vice President-CEO shall annually, after consultation with the Council of Experts, present a report to the Board of Trustees of the activities of the Council of Experts. The Executive Vice President-CEO also shall present a report of the Council of Experts at the stated meeting of the Pharmacopeial Convention.

Section 8

In the event of a vacancy in the Chair of an Expert Committee, the vice chair shall serve in his or her absence. In the event the vice chair is unable to serve, the Executive Vice President-CEO shall appoint an acting Chairperson until a new Chairperson is elected.

Section 9

The Executive Vice President-CEO, after consultation with and upon notice to the Board of Trustees, may appoint advisory bodies to provide advice on policy matters. The Executive Vice President-CEO may also appoint such Stakeholder Forums and Project Teams as deemed necessary for the work of the Convention. Such Stakeholder Forums and Project Teams shall operate pursuant to rules promulgated by the Executive Vice President-CEO and approved by the Board of Trustees.

Section 10

The Executive Vice President-CEO shall serve at the will of the Board of Trustees.

Section 11

Officers shall have the authority and shall perform the duties set forth in these Bylaws or, to the extent consistent with the Bylaws, the duties prescribed by the Board of Trustees, by the Executive Vice President-Chief Executive Officer, or by an officer authorized by the Board to prescribe the duties of such officer. Any designation of duties by the Executive Vice President-CEO or other officer shall be subject to review by the Board of Trustees but shall be in full force and effect in the absence of such review.